News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Científico_Biotecnología_AseBio
A4CELL Celebrates a Remarkable Year with €3 MillionInvestment to Transform Living Single Cell Analysis
Healthcare · Advanced therapies · Financing
This momentousinvestment will serve as the catalyst for revolutionizing the landscape of living…
Miquel_Vila_Perello_CEO_spliceBio
SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease
Healthcare · Drug discovery · Rare diseases · Advanced therapies
Spark secures exclusive worldwide rights to SpliceBio’s proprietary Protein Splicing platform to…
Sidekick_Health
Sidekick Health announces landmark acquisition, expanding its portfolio to offer regulated Prescription Digital Therapeutics
Healthcare
The acquisition of aidhere strengthens Sidekick Health’s digital health offering to patients and…
Salud_Mental_AseBio
ORYZON presents blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder
Healthcare · Drug discovery · Innovative drugs
At the 36th European College of Neuropsychopharmacology congress (ECNP-2023).
renalyse-gensisbiomed-ndp-asebio
Renalyse has successfully closed an investment round of 1 M€ in public and private capital
Access to innovation · Financing
The operation was led by the Mind the Gap program from Botín Foundation, with participation from…
Equipo_ADMIT
ADmit therapeutics closes a €5.4 million funding round led by Clave Capital, through its Clave Innohealth f.c.r. fund
Financing
The European Innovation Council (EIC) Fund and the Alzheimer's Drug Discovery Foundation (ADDF)…
Wendy_Morales_ProductLife_Group
#NewMemberAseBio | "AseBio is an opportunity to help organizations in the sector understand regulation, the changes that occur, and keep their products safe in the market"
Access to innovation
Meet ProductLife Group, our new partner. We spoke with Wendy Morales, business…
Ackermann
"Silence kills"
Healthcare
Studies indicate that more than 60 percent of medication errors are caused by mistakes in…
Ribonuclease H processing the hybrid DNA RNA helix
Simulation tools drive the new generation of therapies based on gene silencing
Healthcare
Researchers at Nostrum Biodiscovery, with the collaboration of other companies, have laid the…